Clinical and Economic Outcomes of Memantine Used in Moderate or Severe Dementia Patients in China: Results from a Health Economic Model
2014 Value in health
Ge, L. | Clay, E. | Yan, J. | Toumi, M. | Milea, D. |
Memantine, model, Value,
In China, memantine is only reimbursed for severe dementia, while approved for moderately severe to severe dementia. The present model assesses the clinical and economic outcomes of extending national recommendations for memantine to moderate dementia.